Nonsteroid antienflamatuar nelerdir

Niacinamide, also known as nicotinamide, is a form of vitamin B3 that can provide a variety of health benefits when taken as a supplement. It can help relieve the discomforts of arthritis and asthma . People with diabetes may benefit from taking it, and it is even thought to help prevent the onset of type I diabetes. Another of the potential benefits of niacinamide is reduction of anxiety, depression, and other psychological issues, and it may also help delay the onset of Alzheimer's disease and Parkinson's disease. Skin conditions like acne and rosacea , as well as the effects of aging like wrinkles , may improve with the use of niacinamide.

Sixty-five trials met the inclusion criteria for this review . Fifty-six trials (19 paediatric trials) contributed data (representing total of 10,005 adults and 3,333 children); 21 trials were of high methodological quality; 44 were published in full-text. All trials pertained to patients with mild or moderate persistent asthma. Trial durations varied from four to 52 weeks. The median dose of inhaled corticosteroids was quite homogeneous at 200 µg/day of microfine hydrofluoroalkane-propelled beclomethasone or equivalent (HFA-BDP eq). Patients treated with anti-leukotrienes were more likely to suffer an exacerbation requiring systemic corticosteroids (N = 6077 participants; risk ratio ( RR ) , 95% confidence interval ( CI ) , ). For every 28 (95% CI 15 to 82) patients treated with anti-leukotrienes instead of inhaled corticosteroids, there was one additional patient with an exacerbation requiring rescue systemic corticosteroids. The magnitude of effect was significantly greater in patients with moderate compared with those with mild airway obstruction ( RR , 95% CI , versus RR , 95% CI , ), but was not significantly influenced by age group (children representing 23% of the weight versus adults), anti-leukotriene used, duration of intervention , methodological quality, and funding source. Significant group differences favouring inhaled corticosteroids were noted in most secondary outcomes including patients with at least one exacerbation requiring hospital admission (N = 2715 participants; RR ; 95% CI to ), the change from baseline FEV 1 (N = 7128 participants; mean group difference ( MD ) 110 mL, 95% CI 140 to 80) as well as other lung function parameters, asthma symptoms, nocturnal awakenings, rescue medication use, symptom-free days, the quality of life, parents' and physicians ' satisfaction. Anti-leukotriene therapy was associated with increased risk of withdrawals due to poor asthma control (N = 7669 participants; RR ; 95% CI to ). For every thirty one (95% CI 22 to 47) patients treated with anti-leukotrienes instead of inhaled corticosteroids, there was one additional withdrawal due to poor control . Risk of side effects was not significantly different between both groups.

Nonsteroid antienflamatuar nelerdir

nonsteroid antienflamatuar nelerdir

Media:

nonsteroid antienflamatuar nelerdirnonsteroid antienflamatuar nelerdirnonsteroid antienflamatuar nelerdirnonsteroid antienflamatuar nelerdirnonsteroid antienflamatuar nelerdir

http://buy-steroids.org